Get the Stockscreener App
0.1953
2.79%
+0.0053
After Hours:
.1999
0.0046
+2.36%
Galera Therapeutics Inc Stock (GRTX) Forecast
The Galera Therapeutics Inc (GRTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.9414, representing a +894.06% increase from the current price of $0.1953. The highest analyst price target is $3.396, and the lowest is $0.4868.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GRTX Price Target
Average 4.092
(+1,995% Upside)
Is Galera Therapeutics Inc (GRTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.52 | Neutral |
| STOCH(9,6) | 51.61 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.000148 | Buy |
| ADX(14) | 11.23 | Neutral |
| William %R | -17.09 | Sell |
| CCI(14) | 115.55 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.1803
Buy
|
0.1834
Buy
|
| MA20 |
0.185
Buy
|
0.1829
Buy
|
| MA50 |
0.1893
Buy
|
0.1861
Buy
|
| MA100 |
0.1871
Buy
|
0.2344
Sell
|
| MA200 |
0.2433
Sell
|
0.5991
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, GRTX could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 5 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on GRTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 56.52 indicates that GRTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.61 indicates that GRTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that GRTX is oversold. This suggests that GRTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.23 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 115.55 indicates that GRTX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term GRTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Galera Therapeutics Inc financial reports and earnings history, Galera Therapeutics Inc (GRTX) stock could reach $10.65 by 2030, $33.06 by 2040 and $52.41 by 2050. See the projected annual prices until 2050 of the Galera Therapeutics Inc stock below:
- Galera Therapeutics Inc (GRTX) is expected to reach an average price of $20.48 in 2035, with a high prediction of $19.48 and a low estimate of $20.34. This indicates an $10,388% rise from the last recorded price of $0.1953.
- Galera Therapeutics Inc (GRTX) stock is projected to chart a bullish course in 2040, with an average price target of $31.35, representing an $15,955% surge from its current level. The forecast ranges from a conservative $32.85 to a sky-high $33.06.
- Our analysts predict Galera Therapeutics Inc (GRTX) to jump 23,154% by 2045, soaring from $41.92 to an average price of $45.42, potentially reaching $45.55. While $41.92 is the low estimate, the potential upside is significant.
- Galera Therapeutics Inc (GRTX) stock is expected to climb by 2050, reaching an average of $49.31, a $25,147% jump from its current level. However, a wide range of estimates exists, with high and low targets of $52.41 and $52.39, respectively, highlighting the market's uncertainty.
Galera Therapeutics Inc Stock (GRTX) Year by Year Forecast
Galera Therapeutics Inc Stock (GRTX) Price Forecast for 2024
Our forecast for GRTX stock price in 2024 now indicates an average price target of $4.092 with a high forecast of $8.1284 and a low forecast of $0.0557. The average prediction reflects an increase of +1,995% from the last recorded price of $0.1953.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $2.2268 | $0.4868 | $3.396 | +1,040% |
| July, 2024 | $1.3961 | $0.7961 | $8.1284 | +614.87% |
| August, 2024 | $4.7516 | $0.16 | $5.1416 | +2,333% |
| September, 2024 | $2.263 | $2.1593 | $7.5085 | +1,059% |
| October, 2024 | $0.7863 | $0.7137 | $1.2863 | +302.64% |
| November, 2024 | $1.1618 | $0.4952 | $4.0841 | +494.88% |
| December, 2024 | $0.6128 | $0.0557 | $1.5934 | +213.75% |
Galera Therapeutics Inc Stock (GRTX) Price Forecast for 2025
Galera Therapeutics Inc Stock (GRTX) is expected to reach an average price of $2.9956 in 2025, with a high prediction of $5.6899 and a low estimate of $0.3012. This indicates an +1,434% rise from the last recorded price of $0.1953.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.9334 | $1.7589 | $2.7834 | +1,402% |
| February, 2025 | $3.008 | $2.3919 | $2.1296 | +1,440% |
| March, 2025 | $1.9726 | $2.0464 | $1.9195 | +910.01% |
| April, 2025 | $1.2332 | $1.5671 | $1.7987 | +531.46% |
| May, 2025 | $1.6122 | $0.7555 | $3.5483 | +725.50% |
| June, 2025 | $1.0477 | $0.6777 | $5.6899 | +436.43% |
| July, 2025 | $2.057 | $0.5149 | $2.997 | +953.23% |
| August, 2025 | $1.7224 | $0.9731 | $2.6408 | +781.93% |
| September, 2025 | $2.9979 | $0.9663 | $3.604 | +1,435% |
| October, 2025 | $2.5672 | $1.7794 | $4.3817 | +1,214% |
| November, 2025 | $0.4926 | $0.3012 | $3.471 | +152.23% |
| December, 2025 | $1.9581 | $0.3025 | $2.0281 | +902.60% |
Galera Therapeutics Inc Stock (GRTX) Price Forecast for 2026
The predicted value for Galera Therapeutics Inc (GRTX) in 2026 is set at an average of $2.5599. Estimates vary from a peak of $5.0768 to a trough of $0.0431, indicating an +1,211% surge from the present price of $0.1953.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.1774 | $0.1535 | $1.3174 | +502.85% |
| February, 2026 | $2.1428 | $0.8312 | $2.8428 | +997.19% |
| March, 2026 | $1.7983 | $1.3983 | $3.2344 | +820.77% |
| April, 2026 | $1.2776 | $0.0663 | $2.0021 | +554.16% |
| May, 2026 | $0.303 | $0.097 | $2.0714 | +55.16% |
| June, 2026 | $1.0985 | $0.0431 | $1.5146 | +462.45% |
| July, 2026 | $5.0022 | $0.7323 | $4.7861 | +2,461% |
| August, 2026 | $5.2768 | $5.1284 | $5.0768 | +2,602% |
| September, 2026 | $2.8975 | $2.2013 | $4.9629 | +1,384% |
| October, 2026 | $3.412 | $3.1636 | $3.382 | +1,647% |
| November, 2026 | $3.7266 | $3.8382 | $3.5943 | +1,808% |
| December, 2026 | $3.2573 | $3.5373 | $3.5988 | +1,568% |
Galera Therapeutics Inc Stock (GRTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Galera Therapeutics Inc (GRTX) is $2.4864, with a high forecast of $3.8364 and a low forecast of $1.1364. This indicates an +1,173% increase from the last price of $0.1953.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4518 | $3.3534 | $3.2918 | +1,667% |
| February, 2027 | $3.8964 | $3.6279 | $3.8364 | +1,895% |
| March, 2027 | $3.6071 | $3.6851 | $3.6348 | +1,747% |
| April, 2027 | $3.7216 | $3.7916 | $3.7216 | +1,806% |
| May, 2027 | $3.6762 | $3.71 | $3.6362 | +1,782% |
| June, 2027 | $3.2768 | $3.3107 | $3.5523 | +1,578% |
| July, 2027 | $2.9014 | $2.7703 | $3.143 | +1,386% |
| August, 2027 | $2.596 | $2.6997 | $2.5698 | +1,229% |
| September, 2027 | $2.3166 | $2.3866 | $2.5045 | +1,086% |
| October, 2027 | $2.2112 | $2.2601 | $2.2389 | +1,032% |
| November, 2027 | $2.0357 | $2.2507 | $2.1296 | +942.37% |
| December, 2027 | $1.0864 | $1.1364 | $1.242 | +456.29% |
Galera Therapeutics Inc Stock (GRTX) Price Forecast for 2028
In 2028, Galera Therapeutics Inc (GRTX) is projected to reach an average price of $0.9141, with a high projection of $1.8161 and a low estimate of $0.0122. This indicates an +368.06% rise from the last price of $0.1953.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.531 | $1.3326 | $1.4454 | +683.92% |
| February, 2028 | $0.9255 | $1.2755 | $1.3472 | +373.91% |
| March, 2028 | $0.1762 | $0.29 | $0.3278 | -9.76% |
| April, 2028 | $0.3092 | $0.1024 | $0.6815 | +58.33% |
| May, 2028 | $0.2285 | $0.1185 | $1.0347 | +17.01% |
| June, 2028 | $0.404 | $0.0176 | $0.754 | +106.85% |
| July, 2028 | $1.8384 | $0.0122 | $0.4917 | +841.31% |
| August, 2028 | $1.7433 | $1.7513 | $1.8161 | +792.61% |
| September, 2028 | $1.5958 | $1.602 | $1.6949 | +717.12% |
| October, 2028 | $1.4933 | $1.4569 | $1.4823 | +664.61% |
| November, 2028 | $1.2286 | $1.2385 | $1.4286 | +529.07% |
| December, 2028 | $1.0641 | $1.0721 | $1.1846 | +444.87% |
Galera Therapeutics Inc Stock (GRTX) Price Forecast for 2029
The 2029 price forecast for Galera Therapeutics Inc Stock (GRTX) is $6.4014 on average, with a high prediction of $12.76 and a low estimate of $0.0469. This represents an +3,178% increase from the previous price of $0.1953.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7988 | $0.807 | $1.0057 | +309.02% |
| February, 2029 | $0.6143 | $0.6329 | $0.7385 | +214.52% |
| March, 2029 | $0.3867 | $0.4321 | $0.538 | +98.01% |
| April, 2029 | $0.284 | $0.3025 | $0.3416 | +45.40% |
| May, 2029 | $0.1415 | $0.0469 | $0.2361 | -27.56% |
| June, 2029 | $10.83 | $11.46 | $10.36 | +5,444% |
| July, 2029 | $9.2763 | $11.02 | $12.28 | +4,650% |
| August, 2029 | $9.8877 | $9.3532 | $8.6346 | +4,963% |
| September, 2029 | $6.3568 | $8.2668 | $7.8045 | +3,155% |
| October, 2029 | $12.75 | $8.1291 | $12.76 | +6,427% |
| November, 2029 | $9.9273 | $11.43 | $11.37 | +4,983% |
| December, 2029 | $9.3764 | $9.7519 | $8.0664 | +4,701% |
Galera Therapeutics Inc Stock (GRTX) Price Forecast for 2030
Galera Therapeutics Inc Stock (GRTX) is expected to reach an average price of $9.3217 in 2030, with a high forecast of $12.93 and a low forecast of $5.7166. This signifies an +4,673% surge from the last price of $0.1953.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.92 | $9.901 | $10.65 | +6,002% |
| February, 2030 | $13.08 | $11.99 | $12.93 | +6,596% |
| March, 2030 | $12.98 | $12.40 | $12.23 | +6,544% |
| April, 2030 | $11.77 | $11.88 | $11.84 | +5,924% |
| May, 2030 | $10.81 | $11.18 | $11.55 | +5,433% |
| June, 2030 | $7.7856 | $8.1333 | $9.8688 | +3,886% |
| July, 2030 | $7.387 | $7.7079 | $7.4324 | +3,682% |
| August, 2030 | $6.9461 | $7.3415 | $6.8492 | +3,457% |
| September, 2030 | $7.1052 | $7.0806 | $6.8129 | +3,538% |
| October, 2030 | $5.5566 | $5.7166 | $7.0675 | +2,745% |
| November, 2030 | $5.8657 | $5.7638 | $5.3657 | +2,903% |
| December, 2030 | $7.7648 | $5.8279 | $7.3748 | +3,876% |
4.27%
2.59%
Cap:
|
Volume (24h):